Citadel Advisors’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.9M Sell
758,110
-325,605
-30% -$17.7M 0.01% 1347
2026
Q1
$41.8M Buy
1,083,715
+577,611
+114% +$24M 0.01% 1528
2025
Q4
$23.5M Buy
506,104
+437,276
+635% +$21.1M ﹤0.01% 2167
2025
Q3
$3.38M Sell
68,828
-163,041
-70% -$8.53M ﹤0.01% 5082
2025
Q2
$12M Buy
+231,869
New +$9.37M ﹤0.01% 2777

Other funds holding HNGE

Citadel Advisors's HNGE Position: Q2 2026 in Review

Citadel Advisors reduced its Hinge Health (HNGE) stake by 30% in Q2 2026, selling an estimated $17.7M and leaving 758,110 shares worth $62.9M. The position accounts for 0.01% of the portfolio, ranked #1347.

Citadel Advisors first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Citadel Advisors held 758,110 shares of Hinge Health worth $62.9M as of Q2 2026.
  • Citadel Advisors sold 325,605 Hinge Health shares in Q2 2026, an estimated $17.7M.
  • Hinge Health made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1347 holding.
  • Citadel Advisors first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.